A Review on Inflammasomes and Cardiovascular Disease: the Nlrp3 Axis as a Therapeutic Frontier
Year: 2025
Type: article
Abstract: Cardiovascular diseases (CVDs) are the leading worldwide cause of morbidity and mortality, inflammation being one of the main factors in their pathology. Inflammasomes, NLRP3 in particular, were identified as central mediators of sterile inflammation processes. NLRP3 inflammasomes are cytosolic multiprotein complexes that control caspase-1 activation and subsequent maturation of pro-inflammatory cytokines IL-1β and IL-18. With growing evidence, NLRP3 inflammasome has been implicated in CVDs like atherosclerosis, myocardial infarction, heart failure, and hypertension. Their activation causes endothelial dysfunction, vascular inflammation, destabilization of plaques, and adverse cardiac remodeling. Targeting the NLRP3 axis therapeutically has been promising in both preclinical and clinical studies, thus presenting NLRP3 as a potential new target in cardiovascular therapy. This study reviews the mechanistic insights of NLRP3 inflammasome activation, its involvement in cardiovascular diseases, current therapeutic strategies, and hurdles in clinical translation. Exploration of this inflammasome axis brings new avenues for precision medicine and targeted interventions for cardiovascular health. Keywords: NLRP3, inflammasome, cardiovascular disease, inflammation, IL-1β, atherosclerosis, myocardial infarction, heart failure.
Author: Rohith Yadav, Shubamalya LG
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6930975479
FWCI:
Cites:
Cited by:
Related to: